Avid Bioservices, Inc. (CDMO): Price and Financial Metrics

CDMO POWR Grades

• CDMO scores best on the Growth dimension, with a Growth rank ahead of 93.63% of US stocks.
• CDMO's strongest trending metric is Growth; it's been moving up over the last 179 days.
• CDMO ranks lowest in Value; there it ranks in the 3rd percentile.

CDMO Stock Summary

• CDMO's current price/earnings ratio is 139.91, which is higher than 95.71% of US stocks with positive earnings.
• With a year-over-year growth in debt of 747.79%, Avid Bioservices Inc's debt growth rate surpasses 98.02% of about US stocks.
• In terms of twelve month growth in earnings before interest and taxes, Avid Bioservices Inc is reporting a growth rate of 289.71%; that's higher than 92.65% of US stocks.
• If you're looking for stocks that are quantitatively similar to Avid Bioservices Inc, a group of peers worth examining would be CLB, XOMA, BLNK, PLBY, and CHCI.
• CDMO's SEC filings can be seen here. And to visit Avid Bioservices Inc's official web site, go to avidbio.com.

CDMO Valuation Summary

• CDMO's price/sales ratio is 15.4; this is 305.26% higher than that of the median Healthcare stock.
• Over the past 243 months, CDMO's EV/EBIT ratio has gone up 130.4.
• Over the past 243 months, CDMO's price/earnings ratio has gone up 461.6.

Below are key valuation metrics over time for CDMO.

CDMO Growth Metrics

The year over year price growth rate now stands at 266.64%.
• Its year over year revenue growth rate is now at 60.58%.
• The 2 year cash and equivalents growth rate now stands at -15.67%.

CDMO's revenue has moved up $62,374,000 over the prior 34 months.

The table below shows CDMO's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	115.977	26.713	9.775
2021-09-30	106.275	26.71	8.292
2021-06-30	101.23	26.513	5.612
2021-03-31	95.868	31.182	3.318
2020-12-31	80.812	16.369	-0.955
2020-09-30	72.591	10.544	-5.266

CDMO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• CDMO has a Quality Grade of C, ranking ahead of 27.37% of graded US stocks.
• CDMO's asset turnover comes in at 0.495 -- ranking 83rd of 682 Pharmaceutical Products stocks.
• COCP, HROW, and IBIO are the stocks whose asset turnover ratios are most correlated with CDMO.

The table below shows CDMO's key quality metrics over time.